Olaf Elbracht

Director/Board Member at APONTIS PHARMA AG

61 year

Health Technology

Commercial Services

Finance

This page is reserved for members. To continue, you must log in or create an account.

Latest insider transactions

An executive increases exposure to an industrial stock

Sector rotation: insiders are more active on clean energy names

New regulatory filing published for executive transactions

Executive Management

Board of Directors

Audit Committee

Institutional Investors

Sell-side Analysts

2026 - Chairman of the Board

2022 - Chief Executive Officer

2018 - Chief Financial Officer

2012 - Strategy Committee Member